Acadia Pharmaceuticals is under fire from CNN again, this time related to a Department of Justice probe into its marketing practices which was revealed by ACAD in a SEC filing last November.
CNN highlights data which shows that Acadia spent more than $8 million on payments to doctors in 2017, including covered meals and travel. Twenty-six doctors received six-figure payments, with the highest paid receiving nearly $200,000.
Acadia CEO, Steve Davis, says that the company is complying with a DOJ civil investigative demand received last September for supply of information and documents related to Nuplazid sales and marketing but that responding to the probe “will require considerable resources.”
https://edition.cnn.com/2019/03/08/health/nuplazid-justice-department-invs/index.html
http://ir.acadia-pharm.com/phoenix....ERVNDPVNFQ1RJT05fUEFHRSZleHA9JnN1YnNpZD01Nw==
https://www.fiercepharma.com/pharma/acadia-discloses-doj-probe-over-nuplazid-marketing
- Forums
- ASX - By Stock
- NEU
- $4.17-$6.31 Val
$4.17-$6.31 Val, page-35
-
- There are more pages in this discussion • 45 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
|
|||||
Last
$20.17 |
Change
0.070(0.35%) |
Mkt cap ! $2.578B |
Open | High | Low | Value | Volume |
$20.39 | $20.53 | $20.14 | $4.102M | 202.5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 249 | $20.15 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$20.31 | 790 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 249 | 20.150 |
2 | 815 | 20.110 |
1 | 99 | 20.100 |
1 | 912 | 20.090 |
1 | 790 | 20.070 |
Price($) | Vol. | No. |
---|---|---|
20.310 | 790 | 1 |
20.350 | 790 | 1 |
20.390 | 1640 | 2 |
20.420 | 790 | 1 |
20.580 | 2400 | 1 |
Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |